Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
Journal of medical genetics(2023)
Abstract
The high prevalence of mosaic meth in patients with breast/ovarian cancer with affected relatives, as well as this first description of a family aggregation of mosaic meth, shows how this de novo event can contribute to hereditary breast/ovarian cancer pedigrees.
MoreTranslated text
Key words
Epigenomics, Heredity, DNA Repair, DNA Methylation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined